Data / Form D filings / PaxVax, Inc.
PaxVax, Inc.: Form D filings
PaxVax, Inc., a pharmaceuticals company in Redwood City, CA, filed 7 Form D notices with the SEC between 2009 and 2014. The latest, on August 11, 2014, reports $34.9 million sold of a $35.5 million offering to 9 investors.
Find out what PaxVax, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 900 VETERANS BOULEVARD, SUITE 500, Redwood City, CA, 94063
- Phone
- (650) 847-1075
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1402296
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 11, 2014 | Amendment | $35,479,182 | $34,929,181 | $550,001 | 9 | Dec 2, 2013 | sec.gov |
| Apr 18, 2014 | New notice | $15,000,000 | $6,000,000 | $9,000,000 | 2 | Apr 4, 2014 | sec.gov |
| Dec 17, 2013 | New notice | $25,659,293 | $22,745,849 | $2,913,444 | 8 | Dec 2, 2013 | sec.gov |
| Oct 31, 2013 | New notice | $3,000,000 | $2,500,000 | $500,000 | 2 | Oct 17, 2013 | sec.gov |
| Oct 1, 2013 | Amendment | $35,106,472 | $35,106,472 | $0 | 19 | Nov 10, 2010 | sec.gov |
| Nov 24, 2010 | New notice | $35,000,000 | $24,296,875 | $10,703,125 | 4 | Nov 10, 2010 | sec.gov |
| Nov 6, 2009 | New notice | $6,000,000 | $2,000,000 | $4,000,000 | 2 | Oct 27, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| HENRY G. COIT, JR. | Director | |
| JAMES B. CONNOLLY | Director | |
| RICHARD B. TONG | Director | |
| KENNETH J. KELLEY | Executive Officer, Director | |
| PHIL B. RUSSELL | Director | |
| HOWARD B. ROSEN | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Aug 11, 2014 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PaxVax, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.